Filtered By:
Source: Journal of Hypertension
Drug: Beta-Blockers
Education: Study
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers
Conclusion:
The vasodilatory beta blocker nebivolol was associated with reduced incident cardiovascular events compared with nonvasodilatory beta blockers. Additional study of other beta blockers is necessary to determine if this is a vasodilatory beta blocker class effect or is specific to nebivolol.
Graphical abstract:
http://links.lww.com/HJH/B916
Source: Journal of Hypertension - May 1, 2022 Category: Cardiology Tags: ORIGINAL ARTICLES Source Type: research